The screened hub genes, IL-6, PTGS2, JUN, NQO1, NOS3, LEPR, NAMPT, CDKN2A, CDKN1A, and Snai1, may be therapeutic targets to prevent MI progression and adverse cardiovascular events. Here, LEPR is linked to myocardial infarction.